Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAO1 for early self-treatment of common cold
2012-000057-31Phase 2Completed
- Sponsor
- Theranos
- Start
- Jan 2012
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Viral Upper Respiratory Infection, nasopharyngitis and influenza-like illness (ILI) comparing TAO1 with Placebo (2 arms). Primary endpoint: Severity of symptoms of common cold. Started Jan 2012; status: completed.
02
Drugs
TAO1
03
Conditions
Viral Upper Respiratory Infectionnasopharyngitisinfluenza-like illness (ILI)
Beyond the preview
Go deeper on 2012-000057-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000057-31.